相关实验视频

Updated: May 23, 2025

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on: September 28, 2017

BMAL1-HIF2A异构体调节心肌损伤的昼夜变化

Wei Ruan^1,2, Tao Li³, In Hyuk Bang⁴

¹Department of Anesthesiology, Critical Care and Pain Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA. Wei.Ruan@uth.tmc.edu.

|April 24, 2025

概括

核心昼夜转录因子BMAL1与HIF2A形成复合体,以昼夜方式调节心肌损伤. 针对这种途径为心脏病患者提供潜在的心脏保护.

科学领域:

心血管生物学
时间生物学
分子医学

背景情况:

急性心肌梗塞是全球的主要健康问题.
心肌梗塞中心脏损伤的严重程度显示出昼夜变化,早晨事件的结果更差.
对于这些心脏损伤的日间变化的分子基础尚不清楚.

研究的目的:

阐明导致心肌损伤的生物周期变化的分子机制.
研究昼夜转录因子BMAL1在心脏损伤调节中的作用.
根据昼夜节律确定心脏保护的潜在治疗点.

主要方法:

用冷电子显微镜 (cryo-EM) 确定BMAL1-HIF2A-DNA复合物的结构.
研究了BMAL1和低氧诱导因子2α (HIF2A) 之间的相互作用.
鉴定出AMPHIREGULIN (AREG) 是BMAL1- HIF2A复合物的基因.

主要成果:

BMAL1与HIF2A形成日间异构体,将昼夜节律和缺氧信号连接起来.
BMAL1- HIF2A复合物增强了HIF2A的转录活性和蛋白质的稳定性.
确定安菲瑞古林 (AREG) 是对白天心肌损伤变化至关重要的节律标.
对BMAL1- HIF2A- AREG途径的药理定位显示了循环节相依赖的心脏保护.

结论:

一个涉及BMAL1和HIF2A的新分子机制解释了心肌损伤的昼夜变化.
BMAL1- HIF2A- AREG通路是白天心脏病发作的关键调节者.
基于循环时钟的药理干预措施对治疗缺血性心脏病具有前景.

更多相关视频

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures

Published on: November 11, 2016

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

相关概念视频

Circadian Rhythms and Gene Regulation

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...